CONGRESS FOR VOTERS

Ted Budd (R-NC)

S.Amdt. 3144

S.Amdt. 3144 · Senate amendment

A Republican amendment with 1 Democratic cosponsor · See the cosponsor

Changes H.R. 3944 — Military Construction and Veterans Affairs, Agriculture, and Legislative Branch Appropriations Act, 2026

Offered

Offered, and not voted on yet. Most amendments never get a vote: the Senate takes up the bill and moves on without them.

Its path through Congress

  1. Introduced
  2. Pending Consideration

What this amendment would do

SA 3144, submitted by Mr. Budd and Mr. Heinrich, aims to add a section to H.R. 3944.

The purpose of this amendment is to require the Food and Drug Administration to use its current regulatory and enforcement powers to stop the importation of GLP-1 and GIP/GLP-1 drugs from the Republic of China or other foreign countries if they seem to be:

  • Counterfeit
  • Unapproved
  • Misbranded
  • Adulterated

This includes blocking bulk drug substances or active pharmaceutical ingredients coming from facilities in China.

To do this, the FDA can use tools such as:

  • Issuing warning letters
  • Starting civil enforcement actions
  • Refusing the entry of these drugs, bulk drug substances, and active pharmaceutical ingredients from those facilities.